We are live on ! Find out more
BLTE

Belite Bio

8 hedge funds and large institutions have $3.87M invested in Belite Bio in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more capital invested

Capital invested by funds: $2.15M → $3.87M (+$1.72M)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

33% more funds holding

Funds holding: 68 (+2)

0.19% more ownership

Funds ownership: 0.29%0.48% (+0.19%)

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AWS
1
Atria Wealth Solutions
New York
$1.82M +$164K +4,742 +10%
Morgan Stanley
2
Morgan Stanley
New York
$615K +$633K +18,308 New
State Street
3
State Street
Massachusetts
$359K +$367K +10,608 New
Qube Research & Technologies (QRT)
4
Qube Research & Technologies (QRT)
United Kingdom
$353K +$131K +3,802 +57%
JP Morgan Chase
5
JP Morgan Chase
New York
$250K +$256K +7,400 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$245K +$251K +7,264 New
Barclays
7
Barclays
United Kingdom
$223K +$230K +6,661 New
PWMG
8
Prestige Wealth Management Group
New Jersey
$7K
Millennium Management
9
Millennium Management
New York
-$280K -8,995 Closed
BAMF
10
BI Asset Management Fondsmaeglerselskab
Denmark
-$92K -2,954 Closed
UBS Group
11
UBS Group
Switzerland
-$21K -683 Closed

BLTE Hedge Fund Activity: Q3 2022 in Review

8 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q3 2022, worth a combined $3.87M — up 80% from $2.15M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BLTE positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $633K. The largest seller was Millennium Management, exiting entirely with an estimated $280K sold.

  • 8 institutional investors held Belite Bio (BLTE) as of Q3 2022, up from 6 in Q2 2022.
  • Funds reported $3.87M of Belite Bio stock for Q3 2022, up 80% quarter-over-quarter.
  • 5 funds opened new Belite Bio positions in Q3 2022 and 3 closed out, a net change of +2 holders.
  • The largest Belite Bio buyer in Q3 2022 was Morgan Stanley, an estimated $633K added.
  • The largest Belite Bio seller in Q3 2022 was Millennium Management, an estimated $280K sold.

Based on aggregated 13F filings for Q3 2022.